Bioventus (BVS) Profit After Tax Growth (3y) (2023 - 2026)
Bioventus (BVS) Profit After Tax Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 3.79% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 3.38% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.85% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 6.53% |
| 10 | Bioventus | 608.36 Mn | 617.88 Mn | 90.77 Mn | 26.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 26.64% |
| Dec 31, 2025 | 34.44% |
| Sep 27, 2025 | 26.90% |
| Jun 28, 2025 | 43.11% |
| Mar 29, 2025 | 43.74% |
| Dec 31, 2024 | -26.36% |
| Sep 28, 2024 | -31.55% |
| Jun 29, 2024 | -83.95% |
| Mar 30, 2024 | -83.01% |
| Dec 31, 2023 | -67.60% |
| Sep 30, 2023 | -45.87% |
| Jul 1, 2023 | 6.38% |
| Apr 1, 2023 | -125.97% |